| ODVCX | RNWEX | ODVCX / RNWEX | |
| Total Expense Ratio | 2.03 | 0.92 | 221% |
| Annual Report Gross Expense Ratio | 2.03 | 0.92 | 221% |
| Fund Existence | 29 years | 23 years | - |
| Gain YTD | -15.225 | 20.944 | -73% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 9.18B | 75.3B | 12% |
| Annual Yield % from dividends | 0.00 | 0.72 | - |
| Returns for 1 year | -16.86 | 19.01 | -89% |
| Returns for 3 years | -8.95 | 43.59 | -21% |
| Returns for 5 years | -39.14 | 10.83 | -362% |
| Returns for 10 years | 1.90 | 90.15 | 2% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PSSPX | 26.89 | 0.10 | +0.37% |
| Principal SmallCap S&P 600 Index R5 | |||
| EXHAX | 25.47 | 0.05 | +0.20% |
| Manning & Napier Pro-Blend Max Term S | |||
| CEFAX | 15.26 | 0.03 | +0.20% |
| Calvert Emerging Markets Advancement A | |||
| SMVLX | 82.19 | N/A | N/A |
| Smead Value Investor | |||
| VEMIX | 33.84 | -0.02 | -0.06% |
| Vanguard Emerging Mkts Stock Idx Instl | |||